(Q44514741)

3 December 2017

title

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status (English)

1 reference

3 December 2017

1 reference

1 reference

John E Morley

1 reference

3 December 2017

Gary A Wittert

1 reference

3 December 2017

Ian M Chapman

1 reference

3 December 2017

Matthew T Haren

1 reference

3 December 2017

Shylie Mackintosh

1 reference

3 December 2017

Penelope Coates

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

The Journals of Gerontology

3 December 2017

published in

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

618-625

1 reference

Predictors of skeletal muscle mass in elderly men and women

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

An examination of research design effects on the association of testosterone and male aging: Results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

A critical evaluation of simple methods for the estimation of free testosterone in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Androgen deficiency in aging men: role of testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Testosterone improves rehabilitation outcomes in ill older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Performance characteristics of the Kin-Com dynamometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

The free androgen index is not valid for adult males

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Which testosterone replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Androgen treatment of abdominally obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.7.M618

21 January 2018

Identifiers

DOI

10.1093/GERONA/58.7.M618

1 reference

3 December 2017

1 reference